Literature DB >> 8536860

Analysis of Ki-ras codon 12 mutations in the duodenal juice of patients with pancreatic cancer.

H Iguchi1, K Sugano, N Fukayama, H Ohkura, K Sadamoto, K Ohkoshi, Y Seo, H Tomoda, A Funakoshi, H Wakasugi.   

Abstract

BACKGROUND & AIMS: Point mutations of the Ki-ras gene at codon 12 have been frequently identified in pure pancreatic juice of patients with pancreatic cancer in studies examining pancreatic cancer tissues. The aim of this study was to examine mutations of the Ki-ras codon 12 in the duodenal juice collected from patients with various pancreatic disorders.
METHODS: The duodenal juice was collected through a Dreiling tube installed in the duodenum during a secretin test. Analysis of the Ki-ras mutations was performed using the enriched polymerase chain reaction--single-strand conformation polymorphism technique.
RESULTS: Point mutations were detected in 12 of 19 patients with pancreatic cancer; of the 12 patients, 10 had ductal tubular adenocarcinoma and 2 intraductal papillary adenocarcinoma. Mutational patterns included GAT (n = 4), GTT (n = 3), CGT (n = 1), and double mutations of GTT and GAT (n = 3) and GAT and CGT (n = 1). In 41 patients with benign pancreatic disorders, a point mutation was detected in only 1 patient with chronic pancreatitis.
CONCLUSIONS: Analysis of the Ki-ras codon 12 mutations in the duodenal juice is useful in the diagnosis of pancreatic cancer.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8536860     DOI: 10.1053/gast.1996.v110.pm8536860

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  13 in total

1.  Inherited predisposition to pancreatic cancer.

Authors:  E Efthimiou; T Crnogorac-Jurcevic; N R Lemoine; T A Brentnall
Journal:  Gut       Date:  2001-02       Impact factor: 23.059

2.  Can K-ras codon 12 mutations be used to distinguish benign bile duct proliferations from metastases in the liver? A molecular analysis of 101 liver lesions from 93 patients.

Authors:  R H Hruban; P D Sturm; R J Slebos; R E Wilentz; A R Musler; C J Yeo; T A Sohn; M L van Velthuysen; G J Offerhaus
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

3.  Detection of oncogenes in chronic pancreatitis.

Authors:  D Paramythiotis; J Kleeff; J Schmidt; M W Büchler; H Friess
Journal:  HPB (Oxford)       Date:  2003       Impact factor: 3.647

Review 4.  [1997 gastroenterology update--II].

Authors:  W Fischbach; V Gross; J Schölmerich; C Ell; P Layer; W E Fleig
Journal:  Med Klin (Munich)       Date:  1998-03-15

5.  Detection of pancreatic carcinoma: diagnostic value of K-ras mutations in circulating DNA from serum.

Authors:  L Theodor; E Melzer; M Sologov; G Idelman; E Friedman; S Bar-Meir
Journal:  Dig Dis Sci       Date:  1999-10       Impact factor: 3.199

Review 6.  Chronic pancreatitis and pancreatic carcinoma.

Authors:  J D Evans; D G Morton; J P Neoptolemos
Journal:  Postgrad Med J       Date:  1997-09       Impact factor: 2.401

7.  Clinicopathological significance of Ki-ras point mutation and p21 expression in benign and malignant exocrine tumors of the human pancreas.

Authors:  M M Song; Y Nio; Y Sato; K Tamura; K Furuse
Journal:  Int J Pancreatol       Date:  1996-10

Review 8.  International consensus on the management of intraductal papillary mucinous neoplasm of the pancreas.

Authors:  Masao Tanaka
Journal:  Ann Transl Med       Date:  2015-11

9.  K-ras oncogene mutations indicate malignancy in cystic tumors of the pancreas.

Authors:  D Bartsch; D Bastian; P Barth; A Schudy; C Nies; O Kisker; H J Wagner; M Rothmund
Journal:  Ann Surg       Date:  1998-07       Impact factor: 12.969

10.  Detection of point mutation in K-ras oncogene at codon 12 in pancreatic diseases.

Authors:  Yue-Xin Ren; Guo-Ming Xu; Zhao-Shen Li; Yu-Gang Song
Journal:  World J Gastroenterol       Date:  2004-03-15       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.